NCT06036563 Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing Status RECRUITING Phase N/A
NCT06034197 Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy Status TERMINATED Phase EARLY_PHASE1
NCT06032338 Trial of Direct Home Delivery of Colorectal Cancer Screening Kit Without Pre-ordering Status ACTIVE_NOT_RECRUITING Phase NA
NCT06026618 Perioperative Management of Preoperative Anemia in Colorectal Cancer Status UNKNOWN Phase N/A
NCT06022887 Time-Restricted Eating and Mindfulness-Based Stress Reduction to Reduce the Risk of Early-Onset Colorectal Cancer Status COMPLETED Phase NA
NCT06019312 L. Plantarum 299v and Gut Microbiome, Diarrhoea, and Clostridioides Difficile Infection in Colorectal Cancer Patients Status UNKNOWN Phase NA
NCT06018077 Chemerin in Colorectal Cancer and Its Relationship With Diet Quality Status UNKNOWN Phase N/A
NCT06016829 Preoperative Nutritional Status and Postoperative Outcomes in Colorectal Cancer Status COMPLETED Phase N/A
NCT06011330 Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal Cancer Status COMPLETED Phase N/A
NCT06010901 A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer. Status UNKNOWN Phase PHASE1
NCT06010888 Fruquintinib With mFOLFOX6/FOLFIRI as First-Line Therapy for Conversion Surgery in mCRC Status RECRUITING Phase PHASE2
NCT06008054 A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors Status RECRUITING Phase PHASE2
NCT06006026 The Safety of Ropivacaine TAP Block Combined With Intravenous Lidocaine in Patients Undergoing Colorectal Cancer Surgery Status RECRUITING Phase NA
NCT06004245 A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06003998 Intraperitoneal Irinotecan With Concomitant FOLFOX and Bevacizumab Status UNKNOWN Phase PHASE2